Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia.

Cheng S, Teuffel O, Ethier MC, Diorio C, Martino J, Mayo C, Regier D, Wing R, Alibhai SM, Sung L.

Br J Cancer. 2011 Aug 23;105(5):606-11. doi: 10.1038/bjc.2011.213. Epub 2011 Jun 21.

2.

Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.

Teuffel O, Cheng S, Ethier MC, Diorio C, Martino J, Mayo C, Wing R, Sung L, Alibhai SM.

Support Care Cancer. 2012 Nov;20(11):2755-64. doi: 10.1007/s00520-012-1397-8. Epub 2012 Feb 17.

PMID:
22350594
3.

Advances in management of low-risk febrile neutropenia.

Teuffel O, Sung L.

Curr Opin Pediatr. 2012 Feb;24(1):40-5. doi: 10.1097/MOP.0b013e32834c4b12. Review.

PMID:
22037219
4.

Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.

Sung L, Feldman BM, Schwamborn G, Paczesny D, Cochrane A, Greenberg ML, Maloney AM, Hendershot EI, Naqvi A, Barrera M, Llewellyn-Thomas HA.

J Clin Oncol. 2004 Oct 1;22(19):3922-9.

PMID:
15459214
5.

Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.

Orme LM, Babl FE, Barnes C, Barnett P, Donath S, Ashley DM.

Pediatr Blood Cancer. 2014 Aug;61(8):1427-33. doi: 10.1002/pbc.25012. Epub 2014 Mar 6.

PMID:
24604835
6.

Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.

Teuffel O, Amir E, Alibhai S, Beyene J, Sung L.

Br J Cancer. 2011 Apr 26;104(9):1377-83. doi: 10.1038/bjc.2011.101. Epub 2011 Apr 5.

7.

Parental perspectives on inpatient versus outpatient management of pediatric febrile neutropenia.

Diorio C, Martino J, Boydell KM, Ethier MC, Mayo C, Wing R, Teuffel O, Sung L, Tomlinson D.

J Pediatr Oncol Nurs. 2011 Nov-Dec;28(6):355-62. doi: 10.1177/1043454211418665.

PMID:
22194148
8.

Developments in the management of febrile neutropenia.

Pascoe J.

Br J Cancer. 2011 Aug 23;105(5):597-8. doi: 10.1038/bjc.2011.304. No abstract available.

9.

Factors affecting treatment choices in paediatric palliative care: comparing parents and health professionals.

Tomlinson D, Bartels U, Hendershot E, Maloney AM, Ethier MC, Sung L.

Eur J Cancer. 2011 Sep;47(14):2182-7. doi: 10.1016/j.ejca.2011.04.038. Epub 2011 Jun 12.

PMID:
21669517
10.

Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.

Teuffel O, Amir E, Alibhai SM, Beyene J, Sung L.

Pediatrics. 2011 Feb;127(2):e279-86. doi: 10.1542/peds.2010-0734. Epub 2011 Jan 10.

PMID:
21220399
11.

Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals.

Tomlinson D, Bartels U, Gammon J, Hinds PS, Volpe J, Bouffet E, Regier DA, Baruchel S, Greenberg M, Barrera M, Llewellyn-Thomas H, Sung L.

CMAJ. 2011 Nov 22;183(17):E1252-8. doi: 10.1503/cmaj.110392. Epub 2011 Oct 17.

12.

Outpatient therapy for febrile neutropenia: clinical and economic implications.

de Lalla F.

Pharmacoeconomics. 2003;21(6):397-413. Review.

PMID:
12678567
13.

Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.

Binz P, Bodmer N, Leibundgut K, Teuffel O, Niggli FK, Ammann RA.

Pediatr Blood Cancer. 2013 May;60(5):799-805. doi: 10.1002/pbc.24380. Epub 2012 Nov 28.

14.

Evolving concepts of management of febrile neutropenia in children with cancer.

Orudjev E, Lange BJ.

Med Pediatr Oncol. 2002 Aug;39(2):77-85. Review.

PMID:
12116054
15.

Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia.

Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, Avritscher EB, Shih YC, Ensor J, Bekele BN, Gralla RJ, Talcott JA, Rolston K.

J Clin Oncol. 2008 Feb 1;26(4):606-11. doi: 10.1200/JCO.2007.13.8222.

PMID:
18235119
16.

Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.

Buysse CM, Raat H, Hazelzet JA, Hop WC, Maliepaard M, Joosten KF.

Crit Care Med. 2008 Feb;36(2):596-602. doi: 10.1097/01.CCM.0000299740.65484.CA.

PMID:
18216608
17.

Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.

Paganini H, Rodriguez-Brieshcke T, Zubizarreta P, Latella A, Firpo V, Casimir L, Armada A, Fernández C, Cáceres E, Debbag R.

Cancer. 2001 Apr 15;91(8):1563-7.

PMID:
11301406
18.

Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.

Santolaya ME, Alvarez AM, Avilés CL, Becker A, Cofré J, Cumsille MA, O'Ryan ML, Payá E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M.

J Clin Oncol. 2004 Sep 15;22(18):3784-9.

PMID:
15365075
19.

Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer.

Hechler T, Blankenburg M, Friedrichsdorf SJ, Garske D, Hübner B, Menke A, Wamsler C, Wolfe J, Zernikow B.

Klin Padiatr. 2008 May-Jun;220(3):166-74. doi: 10.1055/s-2008-1065347.

PMID:
18478489
20.

Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.

Dommett R, Geary J, Freeman S, Hartley J, Sharland M, Davidson A, Tulloh R, Taj M, Stoneham S, Chisholm JC.

Eur J Cancer. 2009 Nov;45(16):2843-9. doi: 10.1016/j.ejca.2009.06.003. Epub 2009 Jul 16.

PMID:
19616427

Supplemental Content

Support Center